Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)

NCT05594667 is registered in ClinicalTrials.gov with Cybin Therapeutics Inc. as lead sponsor.

NCT NCT05594667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05594667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)
Lead sponsor
Cybin Therapeutics Inc.
Phase
Phase 2
Overall status
Withdrawn
Start date
January 1, 2023
Completion date
March 14, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, depressive disorder, major depressive disorder, mild depression, moderate depression